Abstract
During the past decade, mesenchymal stem cells (MSCs) have made their mark as a potential weapon in regenerative medicine. Since their first isolation by Friedenstein in the late 1970s of the last century, MSCs have opened new avenues in the field of regenerative medicine. The main fascination about MSCs lies in their ease of isolation and large ex vivo expansion capacity, as well as demonstrated multipotency and immunomodulatory activities. Basically, several reports have proved that MSCs isolated from different sources possess different characteristics and potentials. In addition, the mechanisms by which these cells can help regenerate tissues and treat several diseases have been proved to be far more complicated than ever thought of. Moreover, a growing body of research has revealed that the therapeutic effects of MSCs occur largely via paracrine signaling and secreted extracellular vesicles, which act as “signalosomes” controlling fundamental cellular functions in recipient cells. In this chapter, we will discuss how MSCs isolated from different sources such as bone marrow; the prototype MSCs, adipose tissue, and umbilical cord differ in their characteristics as potential sources of allogenic versus autologous cell therapy options. Besides, we will clarify the main documented mechanisms of action which MSCs play in regenerative medicine including their differentiation to tissues of mesenchymal versus non-mesenchymal lineages. Additionally, the immune-modulatory effects of MSCs will be discussed as an important arm in their therapeutic potential. Finally, we will discuss the potential of extracellular vesicles produced by MSCs as an emerging cell-free alternative to stem cells therapy.
Similar content being viewed by others
Abbreviations
- BM:
-
Bone marrow
- CM:
-
Conditioned medium
- EVs:
-
Extracellular vesicles
- FDA:
-
Food and Drug Administration
- FGF:
-
Fibroblast growth factor
- GMP:
-
Good Manufacturing Practice
- GvHD:
-
Graft vs host rejection disease
- HGF:
-
Hepatocyte growth factor
- IDO:
-
Indoleamine-pyrrole 2,3-dioxygenase
- IFN-γ:
-
Interferon-γ
- ISCT:
-
International Society for Cellular Therapy
- MSCs:
-
Mesenchymal stem cells
- NK cells:
-
Natural killer cells
- PDL-1:
-
Programmed death ligand-1
- PGE2:
-
Prostaglandin E2
- PRP:
-
Platelet-rich plasma
- SVF:
-
Stromal vascular fraction
- TGF-β1:
-
Transforming growth factor-β1
- TNF-α:
-
Tumor necrosis factor-α
- UC:
-
Umbilical cord
- UCB:
-
Umbilical cord blood
- WJ:
-
Wharton’s jelly
References
Abbaszadeh H, Ghorbani F, Derakhshani M, Movassaghpour AA, Yousefi M, Talebi M, Shamsasenjan K (2020) Regenerative potential of Wharton’s jelly-derived mesenchymal stem cells: a new horizon of stem cell therapy. J Cell Physiol 235(12):9230–9240. https://doi.org/10.1002/jcp.29810
Adolfsson E, Helenius G, Friberg Ö, Samano N, Frøbert O, Johansson K (2020) Bone marrow- and adipose tissue-derived mesenchymal stem cells from donors with coronary artery disease; growth, yield, gene expression and the effect of oxygen concentration. Scand J Clin Lab Invest 80(4):318–326. https://doi.org/10.1080/00365513.2020.1741023
Aguena M, Fanganiello RD, Tissiani LA, Ishiy FA, Atique R, Alonso N, Passos-Bueno MR (2012) Optimization of parameters for a more efficient use of adipose-derived stem cells in regenerative medicine therapies. Stem Cells Int 2012:303610
Alstrup T, Eijken M, Brunbjerg ME, Hammer-Hansen N, Moller BK, Damsgaard TE (2020) Measured levels of human adipose tissue-derived stem cells in adipose tissue is strongly dependent on harvesting method and stem cell isolation technique. Plast Reconstr Surg 145:142–150
Arutyunyan I, Elchaninov A, Makarov A, Fatkhudinov T (2016) Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells Int 2016:6901286
Azandeh S, Orazizadeh M, Hashemitabar M, Khodadadi A, Shayesteh A, Nejad D, Gharravi A et al (2012) Mixed enzymatic-explant protocol for isolation of mesenchymal stem cells from Wharton’s jelly and encapsulation in 3D culture system. J Biomed Sci Eng 5:580–586. https://doi.org/10.4236/jbise.2012.510071
Badowski MS, Harris DT (2012) Collection, processing, and banking of umbilical cord blood stem cells for transplantation and regenerative medicine. Methods Mol Biol 879:279–290. https://doi.org/10.1007/978-1-61779-815-3_16
Bajek A, Gurtowska N, Olkowska J, Maj M, Kazmierski L, Bodnar M, Marszalek A et al (2017) Does the harvesting technique affect the properties of adipose-derived stem cells? – the comparative biological characterization. J Cell Biochem 118:1097–1107
Banyard DA, Salibian AA, Widgerow AD, Evans GR (2015) Implications for human adipose-derived stem cells in plastic surgery. J Cell Mol Med 19:21–30
Barbagallo I, Li Volti G, Galvano F, Tettamanti G, Pluchinotta FR, Bergante S, Vanella L (2017) Diabetic human adipose tissue-derived mesenchymal stem cells fail to differentiate in functional adipocytes. Exp Biol Med 242(10):1079–1085. https://doi.org/10.1177/1535370216681552
Batsali A, Kastrinaki M, Papadaki H, Pontikoglou C (2013) Mesenchymal stem cells derived from Wharton’s jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther 8:144–155
Berebichez-Fridman R, Montero-Olvera PR (2018) Sources and clinical applications of mesenchymal stem cells: state-of-the-art review. Sultan Qaboos Univ Med J 18(3):e264–e277. https://doi.org/10.18295/squmj.2018.18.03.002
Bhartiya D, Shaikh A, Nagvenkar P, Kasiviswanathan S, Pethe P, Pawani H, Mohanty S (2012) Very small embryonic-like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy. Stem Cells Dev 21(1):1–6. https://doi.org/10.1089/scd.2011.0311
Bhat S, Viswanathan P, Chandanala S, Prasanna SJ, Seetharam RN (2021) Expansion and characterization of bone marrow derived human mesenchymal stromal cells in serum-free conditions. Sci Rep 11:3403. https://doi.org/10.1038/s41598-021-83088-1
Bian Y, Deng C, Li W, Lei Z, Li Y, Li X (2016) A comparative study on the biological characteristics of human adipose-derived stem cells from lipectomy and liposuction. PLoS One 11:e0162343
Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, Kluter H (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27:2331–2341
Bjorge IM, Kim SY, Mano JF, Kalionis B, Chrzanowski W (2018) Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine – a new paradigm for tissue repair. Biomater Sci 6:60–78
Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15:641–648
Buccini S, Haider KH, Ahmed RPH, Jiang S, Ashraf M (2012) Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart. Basic Res Cardiol 107(6):301
Can A, Celikkan FT, Cinar O (2017) Umbilical cord mesenchymal stromal cell transplantations: a systemic analysis of clinical trials. Cytotherapy 19:1351–1382
Caplan A (1991) Mesenchymal stem cells. J Orthop Res 9:641–650
Caplan AI (1994) The mesengenic process. Clin Plast Surg 21(3):429–435
Caplan AI (2017) Mesenchymal stem cells: time to change the name! Stem Cells Transl Med 6:1445–1451. https://doi.org/10.1002/sctm.17-0051
Ceccarelli S, Pontecorvi P, Anastasiadou E, Napoli C, Marchese C (2020) Immunomodulatory effect of adipose-derived stem cells: the cutting edge of clinical application. Front Cell Dev Biol 8:236
Chatzistamatiou T, Papassavas A, Michalopoulos E, Gamaloutsos C, Mallis P, Gontika I, Panagouli E et al (2014) Optimizing isolation culture and freezing methods to preserve Wharton’s jelly’s mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank. Transfusion 54:3108–3120
Chen L, Tredget E, Wu P, Wu Y (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3:e1886
Chen MY, Lie PC, Li ZL, Wei X (2009) Endothelial differentiation of Wharton’s jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol 37(5):629–640. https://doi.org/10.1016/j.exphem.2009.02.003
Chen YJ, Liu HY, Chang YT, Cheng YH, Mersmann HJ, Kuo WH, Ding ST (2016) Isolation and differentiation of adipose-derived stem cells from porcine subcutaneous adipose tissues. J Vis Exp 2016:e53886
ClinicalTrials.gov (2019) https://clinicaltrials.gov/
Colao IL, Corteling R, Bracewell D, Wall I (2018) Manufacturing exosomes: a promising therapeutic platform. Trends Mol Med 24:242–256
Conley SM, Hickson LJ, Kellogg TA, McKenzie T, Heimbach JK, Taner T, Tang H et al (2020) Human obesity induces dysfunction and early senescence in adipose tissue-derived mesenchymal stromal/stem cells. Front Cell Dev Biol 8:197. https://doi.org/10.3389/fcell.2020.00197
Da Silva Meirelles L, Chagastelles P, Nardi N (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204–2213
Dai R, Wang Z, Samanipour R, Koo KI, Kim K (2016) Adipose-derived stem cells for tissue engineering and regenerative medicine applications. Stem Cells Int 2016:6737345
Davies LC, Heldring N, Kadri N, Le Blanc K (2017) Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells 35:766–776
De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL et al (2003) Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174:101–109
de Witte SFH, Luk F, Sierra Parraga JM, Gargesha M, Merino A, Korevaar SS, Shankar AS et al (2018) Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells. Stem Cells 36:602–615
Derkus B, Emregul KC, Emregul E (2017) A new approach in stem cell research – exosomes: their mechanism of action via cellular pathways. Cell Biol Int 41:466–475
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
El-Demerdash RF, Hammad LN, Kamal MM, El Mesallamy HO (2015) A comparison of Wharton’s jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy. Regen Med 10:841–855
Farini A, Sitzia C, Erratico S, Meregalli M, Torrente Y (2014) Clinical applications of mesenchymal stem cells in chronic diseases. Stem Cells Int 2014:306573
Fathi E, Farahzadi R (2009) Isolation, culturing, characterization and aging of adipose tissue-derived mesenchymal stem cells: a brief overview. Braz Arch Biol Technol 59:e16150383. https://doi.org/10.1590/1678-4324-2016150383
Ferreira JR, Teixeira GQ, Santos SG, Barbosa MA, Almeida-Porada G, Goncalves RM (2018) Mesenchymal stromal cell Secretome: influencing therapeutic potential by cellular pre-conditioning. Front Immunol 9:2837
Fong C, Chak L, Biswas A, Tan J, Gauthaman K, Chan W, Bongso A (2011) Human Wharton’s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev Rep 7:1–16
Fong C-Y, Subramanian A, Biswas A, Bongso A (2016) Freezing of fresh Wharton’s jelly from human umbilical cords yields high post-thaw mesenchymal stem cell numbers for cell-based therapies. J Cell Biochem 117:815–827
Fontes T, Brandão I, Negrão R, Martins MJ, Monteiro R (2018) Autologous fat grafting: harvesting techniques. Ann Med Surg 36:212–218. https://doi.org/10.1016/j.amsu.2018.11.005
Franquesa M, Mensah FK, Huizinga R, Strini T, Boon L, Lombardo E, DelaRosa O et al (2015) Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells 33:880–891
Frausin S, Viventi S, Verga Falzacappa L, Quattromani MJ, Leanza G, Tommasini A, Valencic E (2015) Wharton’s jelly derived mesenchymal stromal cells: biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem 117(4–5):329–338. https://doi.org/10.1016/j.acthis.2015.02.005
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403
Friedenstein A, Chailakhyan R, Latsinik N, Panasyuk A, Keiliss-Borok I (1974) Stromal cells responsible for transfering the microenvironment of the hemopoeitic tissues: cloning in-vitro and retransplantation in-vivo. Transplantation 17:331–340
Gale AL, Linardi RL, George M, Mammone RM, Ortved KF (2019) Comparison of the chondrogenic differentiation potential of equine synovial membrane-derived and bone marrow-derived mesenchymal stem cells. Front Vet Sci 6:178. https://doi.org/10.3389/fvets.2019.00178
Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S (2015) Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic? Proteomics 15(2–3):260–271
Gatta V, D’Aurora M, Lanuti P, Pierdomenico L, Sperduti S, Palka G, Gesi M et al (2013) Gene expression modifications in Wharton’s jelly mesenchymal stem cells promoted by prolonged in vitro culturing. BMC Genomics 14:635
Gentile P, Piccinno MS, Calabrese C (2019) Characteristics and potentiality of human adipose-derived stem cells (hASCs) obtained from enzymatic digestion of fat graft. Cells 8(3):282. https://doi.org/10.3390/cells8030282
Ghamari A, Daghigh F, Mohebbi A, Rahimi Y, Shojaie L, Zolbin MM (2021) Chapter 3. Caracteristic and regenerative potential of human endometrial stem cells and progenitors. In: Stem cells: from potential to promise. Springer, Singapore
Ghannam S, Pene J, Moquet-Torcy G, Jorgensen C, Yssel H (2010) Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 185:302–312
Gieseke F, Bohringer J, Bussolari R, Dominici M, Handgretinger R, Muller I (2010) Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116:3770–3779
Gnanasegaran N, Govindasamy V, Musa S, Kasim NH (2014) Different isolation methods alter the gene expression profiling of adipose derived stem cells. Int J Med Sci 11:391–403
Goyal U, Jaiswal C, Ta M (2018) Isolation and establishment of mesenchymal stem cells from Wharton’s jelly of human umbilical cord. Bio Protoc 8(4):e2735. https://doi.org/10.21769/BioProtoc.2735
Granero-Moltó F, Weis JA, Miga MI, Landis B, Myers TJ, O’Rear L, Longobardi L et al (2009) Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27:1887–1898
Haider KH (2017) Hematopoietic stem cell transplantation: the quality matters. J Stem Cell Res Ther 7:6
Haider KH, Aramini B (2020) Mircrining the injured heart with stem cell-derived exosomes: an emerging strategy of cell-free therapy. Stem Cell Res Ther 11(1):23. https://doi.org/10.1186/s13287-019-1548-7
Haider KH, Ashraf M (2005) Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol 238:225–235
Haider KH, Aslam M (2018) Cell-free therapy with stem cell secretions: protection, repair and regeneration of the injured myocardium. In: Haider KH, Aziz S (eds) Stem cells: from hype to real hope, Medicine & life sciences. De Gruyter, Berlin. https://doi.org/10.1515/9783110587043-003
Hall MN, Rosenkrantz WS, Hong JH, Griffin CE, Mendelsohn CM (2010) Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study. Vet Ther 11:1–14
Han YF, Tao R, Sun TJ, Chai JK, Xu G, Liu J (2013) Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology 65:819–827
Harris DT (2014) Stem cell banking for regenerative and personalized medicine. Biomedicines 2(1):50–79. https://doi.org/10.3390/biomedicines2010050
Hass R, Kasper C, Böhm S, Jacobs R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9:12
Horwitz E, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini F, Deans R et al (2005) Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 7:393–395
Hu CD, Kosaka Y, Marcus P, Rashedi I, Keating A (2019) Differential immunomodulatory effects of human bone marrow-derived mesenchymal stromal cells on natural killer cells. Stem Cells Dev 28:933–943
Hua J, Gong J, Meng H, Xu B, Yao L, Qian M, He Z et al (2013) Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow. Cell Biol Int 38:198–210
Hyvarinen K, Holopainen M, Skirdenko V, Ruhanen H, Lehenkari P, Korhonen M, Kakela R et al (2018) Mesenchymal stromal cells and their extracellular vesicles enhance the anti-inflammatory phenotype of regulatory macrophages by downregulating the production of interleukin (IL)-23 and IL-22. Front Immunol 9:771
Jackson WM, Nesti LJ, Tuan RS (2010) Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther 10:505–517. https://doi.org/10.1517/14712591003610606
Janockova J, Slovinska L, Harvanova D, Spakova T, Rosocha J (2021) New therapeutic approaches of mesenchymal stem cells-derived exosomes. J Biomed Sci 28:39. https://doi.org/10.1186/s12929-021-00736-4
Jiang S, Haider KH, Niagara MI, Salim A, Ashraf M (2006) Supportive interaction between cell survival signaling and angio-competent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res 99:776–784. https://doi.org/10.1161/01.RES.0000244687.97719.4f
Jiang S, Haider KH, Ahmed RP, Idris NM, Salim A, Ashraf M (2008) Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium. J Mol Cell Cardiol 44(3):582–596. https://doi.org/10.1016/j.yjmcc.2007.11.014
Kamal MM, Kassem DH (2020) Therapeutic potential of Wharton’s jelly mesenchymal stem cells for diabetes: achievements and challenges. Front Cell Dev Biol 8:16–16
Kandoi S, Kumar LP, Patra B, Vidyasekar P, Sivanesan D, Vijayalakshmi S, Rajagopal K et al (2018) Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs. Sci Rep 8:12439. https://doi.org/10.1038/s41598-018-30772-4
Kang JY, Oh M-K, Joo H, Park HS, Chae D-H, Kim J, Lee H-R, Oh I-H, Yu K-R (2020) Xeno-free condition enhances therapeutic functions of human Wharton’s jelly-derived mesenchymal stem cells against experimental colitis by upregulated Indoleamine 2,3-dioxygenase activity. J Clin Med 9:2913. https://doi.org/10.3390/jcm9092913
Kangari P, Talaei-Khozani T, Razeghian-Jahromi I, Razmkhah M (2020) Mesenchymal stem cells: amazing remedies for bone and cartilage defects. Stem Cell Res Ther 11:492
Karp J, Teo GL (2009) Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4:206–216
Kassem DH, Kamal MM (2020a) Mesenchymal stem cells and their extracellular vesicles: a potential game changer for the COVID-19 crisis. Front Cell Dev Biol 8:1035
Kassem DH, Kamal MM (2020b) Therapeutic efficacy of umbilical cord-derived stem cells for diabetes mellitus: a meta-analysis study. Stem Cell Res Ther 11:484
Kassem DH, Kamal MM (2020c) Wharton’s jelly MSCs: potential weapon to sharpen for our battle against DM. Trends Endocrinol Metab 31:271–273
Kern S, Eichler H, Stoeve J, Kluter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294–1301
Khazaei S, Keshavarz G, Bozorgi A, Nazari H, Khazaei M (2021) Adipose tissue-derived stem cells: a comparative review on isolation, culture, and differentiation methods. Cell Tissue Bank. https://doi.org/10.1007/s10561-021-09905-z
Kim HW, Ashraf M, Jiang S, Haider KH (2012) Stem cell based delivery of hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of the infarcted heart function. J Mol Med 90(9):997–1010
Kim D, Staples M, Shinozuka K, Pantcheva P, Kang S, Borlongan C (2013) Wharton’s jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci 14:11692–11712
Kim YS, Choi YJ, Koh YG (2015) Mesenchymal stem cell implantation in knee osteoarthritis: an assessment of the factors influencing clinical outcomes. Am J Sports Med 43:2293–2301
Knudtzon S (1974) In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 43:357
Koh YG, Kwon OR, Kim YS, Choi YJ, Tak DH (2016) Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: 2-year follow-up of a prospective randomized trial. Arthroscopy 32:97–109
Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F (2003) Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101:3722–3729
Kunze KN, Burnett RA, Wright-Chisem J, Frank RM, Chahla J (2020) Adipose-derived mesenchymal stem cell treatments and available formulations. Curr Rev Musculoskelet Med 13:264–280
La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, Di Stefano A et al (2009) Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131:267–282
Lacy KJ, Christopher BR, Natalie P, Erica KG, Wayne MC (2021) Interactions between allogeneic mesenchymal stromal cells and the recipient immune system: a comparative review with relevance to equine outcomes. Front Vet Sci 7:1131. https://doi.org/10.3389/fvets.2020.617647
Lai VK, Afzal MR, Ashraf M, Jiang S, Haider KH (2012) Non-hypoxic stabilization of HIF-1α during coordinated interaction between Akt and angiopoietin-1 enhances endothelial commitment of bone marrow stem cells. J Mol Med 90(6):719–730
Laroye C, Boufenzer A, Jolly L, Cunat L, Alauzet C, Merlin J-L, Yguel C et al (2019) Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study. Stem Cell Res Ther 10:192. https://doi.org/10.1186/s13287-019-1295-9
Le H, Xu W, Zhuang X, Chang F, Wang Y, Ding J (2020) Mesenchymal stem cells for cartilage regeneration. J Tissue Eng 11:2041731420943839
Li N, Hua J (2017) Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci 74:2345–2360
Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y (2014) Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med 34:695–704
Li CY, Wu XY, Tong JB, Yang XX, Zhao JL, Zheng QF, Zhao GB et al (2015a) Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Res Ther 6(1):55. https://doi.org/10.1186/s13287-015-0066-5
Li L-M, Ruan G-X, Huangfu M-Y, Chen Z-L, Liu H-N, Li L-X, Hu Y-L et al (2015b) ScreenFect A: an efficient and low toxic liposome for gene delivery to mesenchymal stem cells. Int J Pharm 488:1–11
Li Z, Bi Y, Wu Q, Chen C, Zhou L, Qi J, Xie D et al (2021) A composite scaffold of Wharton’s jelly and chondroitin sulphate loaded with human umbilical cord mesenchymal stem cells repairs articular cartilage defects in rat knee. J Mater Sci Mater Med 32(4):36. https://doi.org/10.1007/s10856-021-06506-w
Lo Sicco C, Reverberi D, Balbi C, Ulivi V, Principi E, Pascucci L, Becherini P et al (2017) Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization. Stem Cells Transl Med 6:1018–1028
Lories RJ, Luyten FP (2011) The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 7:43–49
Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, Gho YS et al (2014) Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell vesicles 3:26913
Luther KM, Haar L, McGuinness M, Wang Y, Lynch Iv TL, Phan A, Song Y et al (2018) Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells. J Mol Cell Cardiol 119:125–137
Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y (2014) Immunobiology of mesenchymal stem cells. Cell Death Differ 21:216–225
Mahmood A, Lu D, Lu M, Chopp M (2003) Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53:697–703
Mahmoudi M, Taghavi-Farahabadi M, Rezaei N, Hashemi SM (2019) Comparison of the effects of adipose tissue mesenchymal stromal cell-derived exosomes with conditioned media on neutrophil function and apoptosis. Int Immunopharmacol 74:105689
Manferdini C, Paolella F, Gabusi E, Gambari L, Piacentini A, Filardo G, Fleury-Cappellesso S et al (2017) Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro evaluation. Osteoarthr Cartil 25:1161–1171
Marigo I, Dazzi F (2011) The immunomodulatory properties of mesenchymal stem cells. Semin Immunopathol 33:593–602
Marino L, Castaldi MA, Rosamilio R, Ragni E, Vitolo R, Fulgione C, Castaldi SG et al (2019) Mesenchymal stem cells from the Wharton’s jelly of the human umbilical cord: biological properties and therapeutic potential. Int J Stem Cells 12(2):218–226. https://doi.org/10.15283/ijsc18034
Mazini L, Rochette L, Amine M, Malka G (2019) Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs). Int J Mol Sci 20:2523
Mazini L, Rochette L, Admou B, Amal S, Malka G (2020) Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing. Int J Mol Sci 21(4):1306. https://doi.org/10.3390/ijms21041306
McIntosh K, Zvonic S, Garrett S, Mitchell JB, Floyd ZE, Hammill L, Kloster A et al (2006) The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24:1246–1253
Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H (2013) Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med 2:455–463
Moffett A, Loke Y (2003) The immunological paradox of pregnancy: a reappraisal. Placenta 25:1–8
Mohr A, Zwacka R (2018) The future of mesenchymal stem cell-based therapeutic approaches for cancer – from cells to ghosts. Cancer Lett 414:239–249
Mosallaei M, Simonian M, Ehtesham N, Karimzadeh MR, Vatandoost N, Negahdari B, Salehi R (2020) Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication. Cancer Gene Ther 27:854–868
Munoz J, Shah N, Rezvani K, Hosing C, Bollard CM, Oran B, Olson A et al (2014) Concise review: umbilical cord blood transplantation: past, present, and future. Stem Cells Transl Med 3:1435–1443
Murphy J, Fink D, Hunziker E, Barry F (2003) Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48:3464–3474
Najar M, Raicevic G, Kazan HF, de Bruyn C, Bron D, Toungouz M, Lagneaux L et al (2012) Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Rev Rep 8:1188–1198. https://doi.org/10.1007/s12015-012-9408-1
Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N (2019) Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci 76:3323–3348
Nekanti U, Rao V, Bahirvani A, Jan M, Totey S, Ta M (2009) Long-term expansion and pluripotent marker array analysis of Wharton’s jelly-derived mesenchymal stem cells. Stem Cells Dev 19:117–130
Newton WC, Kim JW, Luo JZQ, Luo L (2017) Stem cell-derived exosomes: a novel vector for tissue repair and diabetic therapy. J Mol Endocrinol 59:R155–R165
Niezgoda A, Niezgoda P, Nowowiejska L, Białecka A, Męcińska-Jundziłł K, Adamska U et al (2017) Properties of skin stem cells and their potential clinical applications in modern dermatology. Eur J Dermatol 27:227–236. https://doi.org/10.1684/ejd.2017.2988
Norouzi-Barough L, Shirian S, Gorji A, Sadeghi M (2021) Therapeutic potential of mesenchymal stem cell-derived exosomes as a cell-free therapy approach for the treatment of skin, bone, and cartilage defects. Connect Tissue Res 2021:1–14
Obradovic H, Krstic J, Trivanovic D, Mojsilovic S, Okic I, Kukolj T, Ilic V et al (2019) Improving stemness and functional features of mesenchymal stem cells from Wharton’s jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche. Placenta 82:25–34. https://doi.org/10.1016/j.placenta.2019.05.005
Oggu GS, Sasikumar S, Reddy N, Ella KKR, Rao CM, Bokara KK (2017) Gene delivery approaches for mesenchymal stem cell therapy: strategies to increase efficiency and specificity. Stem Cell Rev Rep 13:725–740
Pirjali T, Azarpira N, Ayatollahi M, Aghdaie MH, Geramizadeh B, Talai T (2013) Isolation and characterization of human mesenchymal stem cells derived from human umbilical cord Wharton’s jelly and amniotic membrane. Int J Organ Transplant Med 4(3):111–116
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI et al (2019) Mesenchymal stem cell perspective: cell biology to clinical progress. npj Regen Med 4:22. https://doi.org/10.1038/s41536-019-0083-6
Polisetti N, Chaitanya VG, Babu PP, Vemuganti GK (2010) Isolation, characterization and differentiation potential of rat bone marrow stromal cells. Neurol India 58:201–208
Prantl L, Eigenberger A, Brix E, Kempa S, Baringer M, Felthaus O (2021) Adipose tissue-derived stem cell yield depends on isolation protocol and cell counting method. Cells 10(5):1113. https://doi.org/10.3390/cells10051113
Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, Monroy R et al (2011) Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant 17:534–541
Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C et al (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129:118–129
Qin Y, Guan J, Zhang C (2014) Mesenchymal stem cells: mechanisms and role in bone regeneration. Postgrad Med J 90:643–647
Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F, Ottonello L et al (2008) Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 26:151–162
Reis M, Mavin E, Nicholson L, Green K, Dickinson AM, Wang XN (2018) Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function. Front Immunol 9:2538
Roura S, Pujal J-M, Gálvez-Montón C, Bayes-Genis A (2015) The role and potential of umbilical cord blood in an era of new therapies: a review. Stem Cell Res Ther 6:123
Russell KA, Chow NH, Dukoff D, Gibson TW, LaMarre J, Betts DH, Koch TG (2016) Characterization and immunomodulatory effects of canine adipose tissue- and bone marrow-derived mesenchymal stromal cells. PLoS One 11:e0167442
Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit M, Janzamin E, Samani FS (2012) Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly. In Vitro Cell Dev Biol Anim 48(2):75–83. https://doi.org/10.1007/s11626-011-9480-x
Salgado AJ, Reis RL, Sousa NJ, Gimble JM (2010) Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 5:103–110
Shaer A, Azarpira N, Aghdaie MH, Esfandiari E (2014) Isolation and characterization of human mesenchymal stromal cells derived from placental decidua basalis; umbilical cord Wharton’s jelly and amniotic membrane. Pak J Med Sci 30(5):1022–1026. https://doi.org/10.12669/pjms.305.4537
Shetty P, Cooper K, Viswanathan C (2010) Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J Transfus Sci 4:14–24
Shi L, Huang H, Lu X, Yan X, Jiang X, Xu R, Wang S et al (2021) Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther 6:58. https://doi.org/10.1038/s41392-021-00488-5
Showalter MR, Wancewicz B, Fiehn O, Archard JA, Clayton S, Wagner J, Deng P et al (2019) Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation. Biochem Biophys Res Commun 512:729–735
Shukla L, Yuan Y, Shayan R, Greening DW, Karnezis T (2020) Fat therapeutics: the clinical capacity of adipose-derived stem cells and exosomes for human disease and tissue regeneration. Front Pharmacol 11:158
Sibov TT, Severino P, Marti LC, Pavon LF, Oliveira DM, Tobo PR, Campos AH et al (2012) Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation. Cytotechnology 64:511–521
Singh TP, Sherpa ML, Pradhan A, Singh TA (2019) Development of a simple selection protocol for optimizing the harvest of mesenchymal stem cells from explanted human umbilical cord Wharton’s jelly. Asian J Med Sci 10(4):1–8. https://doi.org/10.3126/ajms.v10i4.24456
Smith BD, Grande DA (2015) The current state of scaffolds for musculoskeletal regenerative applications. Nat Rev Rheumatol 11:213–222
Song N, Scholtemeijer M, Shah K (2020) Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci 41:653–664
Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M (2006) Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24:1409–1410
Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327–1333
Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L (2009) MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113:6576–6583
Spurway J, Logan P, Pak S (2012) The development, structure and blood flow within the umbilical cord with particular reference to the venous system. Australas J Ultrasound Med 15:97–102. https://doi.org/10.1002/j.2205-0140.2012.tb00013.x
Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J (2012) Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 21(14):2724–2752. https://doi.org/10.1089/scd.2011.0722
Tasso R, Ulivi V, Reverberi D, Lo Sicco C, Descalzi F, Cancedda R (2013) In vivo implanted bone marrow-derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an ectopic bone regenerative niche. Stem Cells Dev 22(24):3178–3191. https://doi.org/10.1089/scd.2013.0313
Tekkatte C, Gunasingh GP, Cherian KM, Sankaranarayanan K (2011) “Humanized” stem cell culture techniques: the animal serum controversy. Stem Cells Int 2011:504723
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7:1535750
Todeschi MR, El Backly R, Capelli C, Daga A, Patrone E, Introna M, Cancedda R et al (2015) Transplanted umbilical cord mesenchymal stem cells modify the in vivo microenvironment enhancing angiogenesis and leading to bone regeneration. Stem Cells Dev 24(13):1570–1581. https://doi.org/10.1089/scd.2014.0490
Toh WS, Lai RC, Zhang B, Lim SK (2018) MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans 46:843–853
Troyer D, Weiss M (2008) Concise review: Wharton’s jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591–599
Um S, Ha J, Choi SJ, Oh W, Jin HJ (2020) Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells. World J Stem Cells 12(12):1511–1528. https://doi.org/10.4252/wjsc.v12.i12.1511
Valencia J, Blanco B, Yanez R, Vazquez M, Herrero Sanchez C, Fernandez-Garcia M, Rodriguez Serrano C et al (2016) Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor. Cytotherapy 18:1297–1311
Varghese J, Griffin M, Mosahebi A, Butler P (2017) Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy. Stem Cell Res Ther 8:45
Varkouhi AK, Monteiro APT, Tsoporis JN, Mei SHJ, Stewart DJ, dos Santos CC (2020) Genetically modified mesenchymal stromal/stem cells: application in critical illness. Stem Cell Rev Rep 16:812–827
Vasandan AB, Shankar SR, Prasad P, Sowmya Jahnavi V, Bhonde RR, Jyothi Prasanna S (2014) Functional differences in mesenchymal stromal cells from human dental pulp and periodontal ligament. J Cell Mol Med 18:344–354. https://doi.org/10.1111/jcmm.12192
Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, Nolta J et al (2019) Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy 21:1019–1024
Wang H, Hung S, Peng S, Huang C, Wei H, Guo Y, Fu Y, Lai M, Chen C (2004) Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 22:1330–1337. https://doi.org/10.1634/stemcells.2004-0013
Wang YQ, Wang M, Zhang P, Song JJ, Li YP, Hou SH, Huang CX (2008) Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction. Chin Med J 121(22):2290–2298
Wang S, Qu X, Zhao R (2012) Clinical applications of mesenchymal stem cells. J Hematol Oncol 5:19
Wang LT, Ting CH, Yen ML, Liu KJ, Sytwu HK, Wu KK, Yen BL (2016a) Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J Biomed Sci 23:76
Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, Shan F et al (2016b) Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton’s jelly as sources of cell immunomodulatory therapy. Hum Vaccin Immunother 12(1):85–96. https://doi.org/10.1080/21645515.2015.1030549
Wei W, Ao Q, Wang X, Cao Y, Liu Y, Zheng SG, Tian X (2021) Mesenchymal stem cell-derived exosomes: a promising biological tool in nanomedicine. Front Pharmacol 11:1954
Wharton T (1656) Adenographia (trans: Freer S). Oxford University Press, Oxford, UK, pp 242–248 (1996)
Xu Y, Meng H, Li C, Hao M, Wang Y, Yu Z, Li Q, Han J, Zhai Q, Qiu L (2010) Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization. Stem Cells Dev 19:1511–1522
Xu L, Liu Y, Sun Y, Wang B, Xiong Y, Lin W, Wei A et al (2017) Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue. Stem Cell Res Ther 8:275. https://doi.org/10.1186/s13287-017-0716-x
Yang XF, He X, He J, Zhang LH, Su XJ, Dong ZY, Xu YJ et al (2011) High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells. J Biomed Sci 18:59
Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, Lim SK (2013) Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev 65:336–341
Zhang J, Liu Y, Chen Y, Yuan L, Liu H, Wang J, Liu Q, Zhang Y (2020a) Adipose-derived stem cells: current applications and future directions in the regeneration of multiple tissues. Stem Cells Int 2020:8810813
Zhang Y, Ding J, Ren S, Wang W, Yang Y, Li S, Meng M et al (2020b) Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia. Stem Cell Res Ther 11:207. https://doi.org/10.1186/s13287-020-01725-4
Zhou Y, Fan W, Prasadam I, Crawford R, Xiao Y (2015) Implantation of osteogenic differentiated donor mesenchymal stem cells causes recruitment of host cells. J Tissue Eng Regen Med 9(2):118–126. https://doi.org/10.1002/term.1619
Zhou K, Guo S, Tong S, Sun Q, Li F, Zhang X, Qiao Y et al (2018) Immunosuppression of human adipose-derived stem cells on T cell subsets via the reduction of NF-kappaB activation mediated by PD-L1/PD-1 and Gal-9/TIM-3 pathways. Stem Cells Dev 27:1191–1202
Zhou Y, Yamamoto Y, Xiao Z, Ochiya T (2019) The immunomodulatory functions of mesenchymal stromal/stem cells mediated via paracrine activity. J Clin Med 8:1025
Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z (2008) Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 26:664–675
Zhu M, Heydarkhan-Hagvall S, Hedrick M, Benhaim P, Zuk P (2013) Manual isolation of adipose-derived stem cells from human lipoaspirates. J Vis Exp 2013:e50585
Zolbin MM, Aliakbari F, Mehdizadeh S, Dayabari SS, Shojaie L, Haider KH, Johnson J (2021) Chapter 4. Ovarian stem cells and progenitors and their regenerative capabilities. In: Stem cells: from potential to promise. Springer, Singapore
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Kamal, M., Kassem, D., Haider, K.H. (2022). Sources and Therapeutic Strategies of Mesenchymal Stem Cells in Regenerative Medicine. In: Haider, K.H. (eds) Handbook of Stem Cell Therapy. Springer, Singapore. https://doi.org/10.1007/978-981-16-6016-0_2-1
Download citation
DOI: https://doi.org/10.1007/978-981-16-6016-0_2-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-6016-0
Online ISBN: 978-981-16-6016-0
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences